Shirley D’Sa

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Constantine S. Tam, Stephen Opat, Shirley D’Sa et al. · Blood · 2020 · 432 citations · Full text

Sutimlimab in Cold Agglutinin Disease

Alexander Röth, Wilma Barcellini, Shirley D’Sa et al. · New England Journal of Medicine · 2021 · 198 citations · Full text

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

Roger G. Owen, Helen O. McCarthy, Simon Rule et al. · The Lancet Haematology · 2019 · 156 citations · Full text

Acalabrutinib Monotherapy, Waldenström Macroglobulinemia, Phase 2 +2

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa et al. · Blood · 2020 · 155 citations · Full text

Assessing the Relation Between Bone Marrow Signal Intensity and Apparent Diffusion Coefficient in Diffusion-Weighted MRI

Anwar R. Padhani, Katherine van Ree, David J. Collins et al. · American Journal of Roentgenology · 2012 · 148 citations